Elenza developed the electronic autofocal intraocular lens, giving patients clear and natural visibility over the full range of vision. Elenzas highly proprietary next generation accommodating iol is designed to give patients a complete visual range, providing effective near. The primary aim is to educate and update rehabilitation and. This listing includes patent applications that are pending as well as patents that have already been granted by the united states patent and trademark office uspto. Products should be designed because of people, not in spite of people. Rudy is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new technology ventures throughout the u. Justia patents patents and patent application resources. In his current ceo role at elenza, rudy mazzocchi has once again strived to overcome the challenges in todays economy to finance and build another medtech company from the ground up. An implantable ophthalmic device with flexible, fluidfilled membranes provide dynamically variable optical power to restore lost accommodation in individuals suffering from presbyopia or aphakia without moving parts or reducing the amount of transmitted light.
Rudy is best known as a medical device and biotechnology entrepreneur, inventor and angel investor whom has a. In 2010, elenza was on the verge of solving that problem. Jane lebkowski, president regenerative patch technologies. It is also our privilege to recognize the leadership of rudy mazzocchi as president and chief executive officer of elenza, an experienced medical device entrepreneur who was recruited to. Other names that rudy uses includes r amplatz, raphael mazzocchi, ralph a mazzocchi, rudy anthony mazzocchi and rudy a mazzocchi. We still have a difficult time believing it, said rudy mazzocchi, elenza s chief executive.
Mazzocchi has 27 years of senior management and financing experience in the medical technology industry and has extensive healthcare background includes an academic, management and venture perspective. Juggling the demands of his dayjob as chief executive officer of elenza, a developmentstage ophthalmology device company, rudy mazzocchi has somehow managed to. He serves currently as cofounderchief executive officer of elenza, inc, an ophthalmology company that has developed an electroactive, autofocusing, implantable lens. Aerie pharmaceuticals competitors, revenue and employees. The following 2 pages are in this category, out of 2 total. Xtnt, a leader in the development of regenerative medicine products and medical devices, today announced the appointment of paul buckman, eric timko, and rudy mazzocchi to. Elenza develops an accommodative iol to address the limitations of standard iols. That is exactly what serial entrepreneur rudy mazzocchi has with the earlystage company elenza, which mazzocchi says is presently considering acquisition opportunities. Attendees as of november 5th, 2012 ophthalmology innovation. And there is certainly no disputing the incredible success of medical device entrepreneur and investor rudy mazzocchi, who is currently the ceo of elenza.
This trait is rare in a world full of outsidethebox thinkers who typically rely on others to a raise the capital and b build the processes necessary to execute upon the novel strategiesconcepts. The registered agent on file for this company is ct corporation system and is located at 4701 cox road, suite 285, glen allen, va 230600000. He has decades of senior management and financing experience in the medical technology industry and has founded and led five. Aerie pharmaceuticals provides 2020 company and guidance update associated with covid19. The stink of having the market leader walk away from their investment commitment, for no. Elenza s ceo stated, ive reached out to 63 venture funds over the past 18 months, and the most prevalent reason for passing was because we do not yet have clinical data or revenues. More than 150 patents and patent applications have been filed. Since taking over as ceo of elenza, mazzocchi has launched some 50 patents and founded a spate of startups across a wide swath of industries, from oncology to neurosurgery to cardiology. It is also our privilege to recognize the leadership of rudy mazzocchi as. He is currently the ceo of elenza, executive chairman of establishment labs holdings, inc. Mazzocchi salary income and net worth data provided by people ai provides an estimation for any internet celebritys real salary income and net worth like rudy a.
Lessons from of a serial medical device entrepreneur. Clare boothe luce postdoctoral fellow at the california institute of technology in biology under. Rudy mazzocchi isnt your average serial entrepreneur. Virginia company alleges alcon stole trade secrets on lens. Rudy mazzocchi has filed for patents to protect the following inventions. Use the pitchbook platform to explore the full profile. Elenza is targeting the 25 million cataract operations that occur each year in the world, as well as the 100 million pairs of multifocal eyewear that are sold each year worldwide. As recently described in an interview on biotuesdays, elenza combines nanotechnology, artificial intelligence neural networksbased memory, and advanced. Rudy mazzocchi is chief executive officer of elenza roanoke, va. Rudy mazzocchi brings 25 years of senior management and financing experience in the medical technology industry. Rudy mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Despite having no formal business training, mazzocchi has managed to parlay a background in biochemistry and biophysics into a successful business career that has launched a bevy of thriving startups acquired by.
Alcon laboratories holding corporation alcon develops and markets standard cataract replacement lenses, called intraocular lenses iol. Elenza was an ophthalmic company that sought to develop an electroactive intraocular lens eaiol. Rudy is a sharpminded visionary, who is able to actually implement upon his various farreaching concepts and aspirational goals. The emergence of biomarkers linking disease and treatment effects in a clear manner presents an opportunity to change the current drug development paradigm, which could lead to more costefficient and higherquality clinical trials. This will probably be the biggest thing ill ever do, he said. Amitava gupta, along with ceo rudy mazzocchi, designed a revolutionary accommodative iol sometimes also. Medical device veteran and author, rudy mazzocchi is. Rudy mazzocchi is 61 years old today because rudy s birthday is on 12051958. Elenza s headquarters is located in roanoke, virginia, usa 24019. Rudy anthony mazzocchi was born in pittsburgh, pennsylvania where he attended the university of pittsburgh as a premed student and then went on to graduate studies at ucla where he worked in the first human genetic engineering lab. Actuating the device causes the fluidfilled membrane to change.
Rudy s incredibly impressive medtech career includes obtaining more than 50 patents, as well as founding or cofounding 11 companies across several medical specialties including cardiology, oncology, orthopedics, neurosurgery, and embryonic. Materials selection and iso 10993 biocompatibility update. Try any of our foolish newsletter services free for 30 days. The wisdom behind the strategies that have driven elenza s success, from not rushing new products to market to. Our products follow this logic and cater to the individual. Founded in march of 20, laforge optical is a company that designs and markets eyewear with an embedded headsup display system. Creating an autofocusing intraocular lens mddi online. See the complete profile on linkedin and discover rudy a. View rudy mazzocchi s business profile as chief executive officer at elenza, inc find contacts direct phone number, email address, work history, and more.
Mazzocchis profile on linkedin, the worlds largest professional community. Rudy mazzocchi joins the greatbatch board of directors as. Awardwinning novelist and medtech executive prepares for. How elenza got to this device, with plans for ce mark approval within 18 to 22 months, is a great example of how advanced electronics are spurring innovation. Mazzocchi will then end with an animated description of his next novel, equity of fear, anticipated for release in february of 20. Serving as chief executive officer of elenza, rudy mazzocchi has once again strived to overcome the challenges in todays economy to finance and build another medtech. Rudy mazzocchi anthony, 61 indian harbour beach, fl. Before moving to rudy s current city of indian harbour beach, fl, rudy lived in satellite beach fl and rockledge fl. Rudy s incredibly impressive medtech career includes obtaining more than 50 patents, as well as founding or cofounding 11 companies across several medical specialties including cardiology, oncology, orthopedics, neurosurgery, and embryonic stemcell development. Intraocular lens to compete in the multibillion dollar iol market.
Xtant medical announces changes to its executive management and board of directors belgrade, mont. Mazzocchi s profile on linkedin, the worlds largest professional community. Medical device veteran and author, rudy mazzocchi is honored as one of top 50 innovators at the 20 venture summit conference share article as chief executive officer of elenza, inc. Mazzocchi to its board of directors originally appeared on. Vascular pathways names rudy mazzocchi executive chairman. He is currently the ceo of elenza, executive chairman of establishment labs.
Rudy mazzocchi is best known as a medical device and biotechnology entrepreneur, inventor, and angel investor, with a history of starting new. The companys filing status is listed as 00 active and its file number is f175387. Rudy mazzocchi inventions, patents and patent applications. Mazzocchi has been elected to its board of directors. Newsletter update norris needs everything as soon as possible so he can publish next week. Wells student health care entrepreneurship competition winner 4 p.
Information on acquisition, funding, investors, and executives for elenza. Mazzocchi founded and sold several companies in the medical space including microvena, vascular science, inc. Elenza involves in developing the electronic auto focal intraocular lens to iol market. Indicate by check mark whether the registrant is a shell company as defined in rule 12b2 of the exchange act. Fluor early career chair of engineering and associate professor of chemical engineering and materials science.
411 710 424 32 352 128 220 1458 965 1158 967 39 777 1196 600 365 1304 1518 227 1204 675 340 1091 951 847 518 1499 1094 406 311 286 308 911 595